United States · FDA National Drug Code directory

Fexofenadine Hydrochloride and Pseudoephedrine Hydrochloride

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference: 41415-995_aac48a0b-2b28-4c14-9baa-84c08713e6c2
Product NDC: 41415-995
Form: TABLET, EXTENDED RELEASE
Composition / generic term: fexofenadine hydrochloride and pseudoephedrine hydrochloride
Labeler: PUBLIX SUPER MARKETS, INC
Marketing category: ANDA
Marketing start / end (source format): 20211108
Source listing expiry: 20261231

Source-listed ingredients

FEXOFENADINE HYDROCHLORIDE — 60 mg/1
PSEUDOEPHEDRINE HYDROCHLORIDE — 120 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

1 BLISTER PACK in 1 CARTON (41415-995-20) / 20 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 41415-995-20
1 BLISTER PACK in 1 CARTON (41415-995-30) / 30 TABLET, EXTENDED RELEASE in 1 BLISTER PACK · 41415-995-30

Source and coverage

Open FDA National Drug Code directory →

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →